Health care stocks rose late Friday afternoon, with the NYSE Health Care Index up 0.5% and the Health Care Select Sector SPDR Fund (XLV) adding 0.7%.
The iShares Biotechnology ETF (IBB) was 0.9% higher.
In corporate news, BioXcel Therapeutics (BTAI) shares jumped 24% after the company regained compliance with Nasdaq's minimum closing bid price rule.
Owens & Minor (OMI) shares surged 40% after it reported better-than-expected quarterly results and a share buyback plan Friday.
DocGo (DCGO) shares fell past 21% after the company reported a Q4 net loss, surprising analysts who expected a profit.
Praxis Precision Medicines (PRAX) shares dropped 41%. An independent data monitoring committee overseeing the company's study 1 of the Essential3 program of ulixacaltamide in essential tremor recommended that the study be "stopped for futility."
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。